Related Experiment Videos
[Hypertension after gestational hyperglycemia]
Luciana C Gonçalves1, Márcia R Gabaldi Silva, José Carlos Peraçoli
1Departamento de Clínica Médica, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP.
Arquivos Brasileiros De Endocrinologia E Metabologia
|September 27, 2005
Summary
Women with gestational diabetes mellitus (GDM) and gestational hyperglycemia (GHG) during pregnancy face a doubled risk of developing hypertension later in life. This highlights a significant long-term health concern for these women.
Area of Science:
- Obstetrics and Gynecology
- Endocrinology
- Cardiovascular Health
Context:
- Pregnancy-induced glucose intolerance, including gestational hyperglycemia (GHG) and gestational diabetes mellitus (GDM), affects a significant number of women.
- Long-term health outcomes following pregnancy-related glucose abnormalities are crucial for preventative care.
- Hypertension is a prevalent chronic condition with serious health implications.
Purpose:
- To investigate the long-term frequency of hypertension in women categorized by their glucose tolerance status during a previous pregnancy.
- To compare hypertension incidence across four groups: normal glucose tolerance (NGT), GHG, GDM, and GDM plus GHG.
- To identify specific pregnancy glucose intolerance profiles associated with increased hypertension risk post-pregnancy.
Summary:
- A study followed 535 women, categorized into NGT, GHG, GDM, or GDM plus GHG groups, assessing hypertension frequency 3-12 years postpartum.
- Hypertension was significantly more frequent in the GDM plus GHG group (40.9%) compared to the NGT group (23.6%).
- Women in the GDM plus GHG group had double the risk of developing hypertension, independent of other clinical parameters.
Impact:
- Identifies a significantly elevated hypertension risk for women with a history of both GDM and GHG.
- Suggests that women with GDM plus GHG require vigilant cardiovascular monitoring post-pregnancy.
- Underscores the importance of managing pregnancy glucose abnormalities to mitigate future chronic disease risk, including hypertension and type 2 diabetes.